Cargando…

Immunoreactive insulin stability in horses at risk of insulin dysregulation

BACKGROUND: Diseases associated with insulin dysregulation (ID), such as equine metabolic syndrome and pituitary pars intermedia dysfunction, are of interest to practitioners because of their association with laminitis. Accurate insulin concentration assessment is critical in diagnosing and managing...

Descripción completa

Detalles Bibliográficos
Autores principales: Leschke, Dakota H., Muir, Genevieve S., Hodgson, Jack K., Coyle, Mitchell, Horn, Remona, Bertin, François‐René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872612/
https://www.ncbi.nlm.nih.gov/pubmed/31617618
http://dx.doi.org/10.1111/jvim.15629
_version_ 1783472522752163840
author Leschke, Dakota H.
Muir, Genevieve S.
Hodgson, Jack K.
Coyle, Mitchell
Horn, Remona
Bertin, François‐René
author_facet Leschke, Dakota H.
Muir, Genevieve S.
Hodgson, Jack K.
Coyle, Mitchell
Horn, Remona
Bertin, François‐René
author_sort Leschke, Dakota H.
collection PubMed
description BACKGROUND: Diseases associated with insulin dysregulation (ID), such as equine metabolic syndrome and pituitary pars intermedia dysfunction, are of interest to practitioners because of their association with laminitis. Accurate insulin concentration assessment is critical in diagnosing and managing these diseases. HYPOTHESIS/OBJECTIVES: To determine the effect of time, temperature, and collection tube type on insulin concentrations in horses at risk of ID. ANIMALS: Eight adult horses with body condition score >6/9. METHODS: In this prospective study, subjects underwent an infeed oral glucose test 2 hours before blood collection. Blood samples were divided into ethylenediaminetetraacetic acid, heparinized, or serum tubes and stored at 4 or 20°C. Tubes were centrifuged and analyzed for insulin by a chemiluminescent assay over 8 days. Changes in insulin concentrations were compared with a linear mixed effects model. RESULTS: An overall effect of time, tube type and temperature was identified (P = .01, P = 0.001, and P = 0.001, respectively). Serum and heparinized samples had similar concentrations for 3 days at 20°C and 8 days at 4°C; however, after 3 days at 20°C, heparinized samples had significantly higher insulin concentrations (P = .004, P = .03, and P = .03 on consecutive days). Ethylenediaminetetraacetic acid samples had significantly lower insulin concentrations regardless of time and temperature (P = .001 for all comparisons). CONCLUSIONS AND CLINICAL IMPORTANCE: These results suggest an ideal protocol to determine insulin concentrations involves using serum or heparinized samples with analysis occurring within 3 days at 20°C or 8 days at 4°C.
format Online
Article
Text
id pubmed-6872612
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68726122019-11-25 Immunoreactive insulin stability in horses at risk of insulin dysregulation Leschke, Dakota H. Muir, Genevieve S. Hodgson, Jack K. Coyle, Mitchell Horn, Remona Bertin, François‐René J Vet Intern Med EQUID BACKGROUND: Diseases associated with insulin dysregulation (ID), such as equine metabolic syndrome and pituitary pars intermedia dysfunction, are of interest to practitioners because of their association with laminitis. Accurate insulin concentration assessment is critical in diagnosing and managing these diseases. HYPOTHESIS/OBJECTIVES: To determine the effect of time, temperature, and collection tube type on insulin concentrations in horses at risk of ID. ANIMALS: Eight adult horses with body condition score >6/9. METHODS: In this prospective study, subjects underwent an infeed oral glucose test 2 hours before blood collection. Blood samples were divided into ethylenediaminetetraacetic acid, heparinized, or serum tubes and stored at 4 or 20°C. Tubes were centrifuged and analyzed for insulin by a chemiluminescent assay over 8 days. Changes in insulin concentrations were compared with a linear mixed effects model. RESULTS: An overall effect of time, tube type and temperature was identified (P = .01, P = 0.001, and P = 0.001, respectively). Serum and heparinized samples had similar concentrations for 3 days at 20°C and 8 days at 4°C; however, after 3 days at 20°C, heparinized samples had significantly higher insulin concentrations (P = .004, P = .03, and P = .03 on consecutive days). Ethylenediaminetetraacetic acid samples had significantly lower insulin concentrations regardless of time and temperature (P = .001 for all comparisons). CONCLUSIONS AND CLINICAL IMPORTANCE: These results suggest an ideal protocol to determine insulin concentrations involves using serum or heparinized samples with analysis occurring within 3 days at 20°C or 8 days at 4°C. John Wiley & Sons, Inc. 2019-10-16 2019 /pmc/articles/PMC6872612/ /pubmed/31617618 http://dx.doi.org/10.1111/jvim.15629 Text en © 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle EQUID
Leschke, Dakota H.
Muir, Genevieve S.
Hodgson, Jack K.
Coyle, Mitchell
Horn, Remona
Bertin, François‐René
Immunoreactive insulin stability in horses at risk of insulin dysregulation
title Immunoreactive insulin stability in horses at risk of insulin dysregulation
title_full Immunoreactive insulin stability in horses at risk of insulin dysregulation
title_fullStr Immunoreactive insulin stability in horses at risk of insulin dysregulation
title_full_unstemmed Immunoreactive insulin stability in horses at risk of insulin dysregulation
title_short Immunoreactive insulin stability in horses at risk of insulin dysregulation
title_sort immunoreactive insulin stability in horses at risk of insulin dysregulation
topic EQUID
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872612/
https://www.ncbi.nlm.nih.gov/pubmed/31617618
http://dx.doi.org/10.1111/jvim.15629
work_keys_str_mv AT leschkedakotah immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation
AT muirgenevieves immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation
AT hodgsonjackk immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation
AT coylemitchell immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation
AT hornremona immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation
AT bertinfrancoisrene immunoreactiveinsulinstabilityinhorsesatriskofinsulindysregulation